MyFinsight
Home
Blog
About
Contact
Accounts receivable,
related party
$259,723
Cash
$271
Prepaid expenses
$200
Total current assets
$260,194
Total assets
$260,194
Retained earnings
(deficit)
-$21,667,546
Other comprehensive
income
-$222,580
Total liabilities &
stockholders equity...
$260,194
Total stockholders
equity (deficit)
-$5,358,868
Additional paid in capital
$16,480,634
Common stock (.0001 par
value) 5,800,000,000...
$35,144
Preferred stock,
value-Series APreferred...
$15,475
Preferred stock,
value-Series MPreferred...
$3
Preferred stock,
value-Series NCPreferred...
$2
Total liabilities
$5,619,062
Total current
liabilities
$5,619,062
Accrued expenses
$1,985,896
Derivative liability
$1,278,763
Unearned income
$1,275,331
Convertible notes payable,
net of unamortized...
$817,717
Notes
payable-Nonrelated Party
$132,503
Other current
liabilities
$99,776
Accounts payable
$20,150
Notes
payable-Related Party
$8,926
Back
Back
Balance Sheet
source: myfinsight.com
Regen BioPharma Inc (RGBPP)
Regen BioPharma Inc (RGBPP)